Natalie Elizabeth Goldberger, PhD

*** ********* ******* **.

Atlanta, GA 30350

301-***-****

aco3iz@r.postjobfree.com

http://www.linkedin.com/pub/natalie-goldberger/12/b36/7a4

. Highly accomplished and results-oriented medical research PhD scientist

with over 10 years of experience in scientific research and medical

communications seeks to apply her impressive clinical research background

and exceptional critical thinking skills as a Medical Writer.

AREAS OF EXPERTISE, CORE COMPETENCIES

. Medical Writing Skills:

. Wrote four needs assessment grants covering such topics as

immunotherapy, metastatic melanoma, triple-negative breast cancer

(TNBC) and ER-positive (ER+) breast cancer.

. Wrote eight high-level executive summaries for national advisory

boards capturing the clinical development highlights within the

treatment landscape.

. Published eight peer-reviewed manuscripts on original preclinical

oncology research.

. Knowledge of biomedical databases, Boolean logic/operators, medical

terminology and basic statistical/clinical concepts.

. Superb data interpretation and medical writing skills, including

grammatical, editorial, and proofreading skills.

. Regulatory Affairs Skills:

. Regulatory Affairs Certificate: Pharmaceuticals from the Regulatory

Affairs Professional Society (RAPS).

. Member of the Regulatory Affairs Professional Society (RAPS).

. Medical Research Skills: Over 10 years preclinical research experience

identifying and validating cancer biomarkers using animal models combined

with high-throughput genetic profiling techniques.

. Leadership Skills: Independently led five cancer research projects to

successful conclusion while establishing productive collaborations and

mentoring a number of colleagues.

. Teamwork Skills: Worked effectively within a 15 person cross-functional

team structure to produce a high impact healthcare report for the

Secretary of Defense.

PROFESSIONAL EXPERIENCE

Associate Director, Educational Development, Medical Affairs

Imedex, LLC (Atlanta, GA)

October, 2014 - January, 2015

Job Description: Lead the development of scientific and clinical content

for selected educational programs, liaising with chairpersons and/or

thought leaders as instructed. The role involved gathering and evaluating

the necessary clinical and scientific information in the marketplace for

development into successful medical education programs.

Primary Responsibilities:

. Translated complex scientific/clinical information regarding concepts and

directions in patient care, unmet medical needs and research

opportunities within therapeutic areas into educational programs.

. Wrote and developed needs assessments for educational medical grants,

including editing final grant requests, and developing original content.

. Traveled to and participated in proprietary medical conferences to attend

lectures, cultivate key relationships and oversee program-specific

operations.

Natalie E. Goldberger, PhD (Page 2)

. Maintained awareness and enforced implementation of FDA, AMA, ACCME and

other relevant regulations.

Medical Writer, Medical Communication

TRM Oncology (Atlanta, GA)

October, 2013 - July, 2014

Job Description: Responsible for the creation, delivery and execution of

scientific/clinical content within client-sponsored Advisory Boards and

Steering Committees attended by KOLs, TLs, and HCPs. Projects were

successfully executed for such clients as Bayer, Novartis, Celgene, Incyte,

and AstraZeneca.

Primary Responsibilities:

. Assisted in the creation of balanced and objective scientific/clinical

oncology presentations delivered by KOLs and pharmaceutical clients at

national advisory boards and other approved meetings.

. Worked effectively independently and within cross functional teams,

including internal/external networking, to complete client projects in a

timely and productive manner.

. Remained abreast of the current literature, therapeutic issues and

treatment landscape related to oncology pharmaceutical agents.

. Traveled extensively to manage and document the

scientific/medical/clinical content presented at national advisory boards

and steering committee meetings.

. Applied knowledge of treatment guidelines (e.g., NCCN, ASCO, ASH, and

ESMO) and clinical research processes to verify and supplement medical

communications content.

Healthcare Data Analyst

Dynamics Research Corporation (Arlington, VA)

November, 2012 - October, 2013

Job Description: Collected program effectiveness information (e.g.,

funding, staff) from 167 psychological health programs to produce a high

level summary report for the Office of the Secretary of Defense (OSD)

Postdoctoral Research Fellow, Biomarker Discovery in Breast Cancer

National Institutes of Health (Bethesda, MD)

National Cancer Institute, Laboratory of Cancer Biology & Genetics

April, 2008 - April, 2012

Research Focus: Identification of microRNA associated with breast cancer

tumorigenesis and metastasis

Research Assistant, Biochemistry of the Androgen Receptor

Ohio State University (Columbus, OH)

College of Pharmacy, Biophysics Department

June, 2002 - April, 2008

Research Focus: Identification of the molecular mechanisms driving

selective androgen receptor tissue-selectivity

Biologist, Biomarker Discovery in Breast and Prostate Cancer

National Institutes of Health (Bethesda, MD)

National Human Genome Research Institute, Cancer Genetics Branch

July, 1999 - June, 2002

Research Focus: Identification of prostate cancer and breast cancer

progression biomarkers

Natalie E. Goldberger, PhD (Page 3)

Clinical Research Assistant, Clinical Mutation Identification

Georgetown University Medical Center (Washington, DC)

Institute for Molecular and Human Genetics

July, 1998 - June, 1999

Research Focus: Identification of mutations and polymorphisms in genes

MLH1 and MSH2

MEDICAL WRITING

. Wrote four needs assessment grants on immunotherapy, metastatic melanoma,

triple-negative breast cancer (TNBC) and ER-positive breast cancer.

. Wrote the executive summaries for 8 national advisory boards focused on

the development and use of clinical oncology agents

. Wrote the data analysis section of the Psychological Health Initiative

report for the Office of the Secretary of Defense (May 2013)

. Wrote the After Action Report on the Psychological Health Initiative for

the Defense Centers of Excellence (DCoE)

. Medical writer for the Office of Intramural Training and Education, NIH

(2011 - 2012)

. Scientific writer for NIH Catalyst, Intramural Scientist Publication, NIH

(2009 - 2012)

MEDICAL PRESENTATIONS

. Presented research results at the AACR: Noncoding RNAs and Cancer Meeting

(January 8-11, 2012)

Invited guest speaker for the Models of Human Cancers Consortium (MMHCC)

meeting (June, 2011)

. Presented research results at the NIH Research Festival (October 24-28,

2011)

. Presented research results at the American Association of Cancer Research

(April 2011)

. Presented research results at the NIH Research Festival (October 5-6,

2010)

. Presented research results at the MRS-AACR Joint Conference on Metastasis

and the Tumor Microenvironment (September 12-15, 2010)

. Invited guest speaker for the Ohio University Physics Program (January

2007)

. Presented research results at the OSU Molecular Life Sciences Symposium

(May 2007)

. Presented research results at the OSU College of Pharmacy Research Day

(May 2007)

. Presented research results at the Endocrine Society's 88th Annual Meeting

(June 2006)

. Presented research results at the American Association of Cancer Research

(April 2002)

LEADERSHIP SKILLS

. Clinical content lead for The 17th Annual Symposium on Anti-Angiogenesis

and Immune Therapies for Cancer conference (February 2015)

. Clinical content lead for an advisory board on ovarian cancer (June 2014)

. Clinical content lead for three advisory boards on polycythemia vera

(January - May 2014)

COMPUTER AND STATISTICAL SKILLS

. Solid computer skills including proficiency with Microsoft Word, EndNote,

Outlook, PowerPoint, and Excel.

. Scientific and Statistical Applications: Partek Genomics Suite,

Ingenuity Pathways Analysis, GraphPad Prism, Sequence Navigator, BLAST,

GenBank, SEQUEST

Natalie E. Goldberger, PhD (Page 4)

EDUCATION

Regulatory Affairs Certificate: Pharmaceuticals

Regulatory Affairs Professional Society (RAPS)

Covered such topics: GCP/GLP/CMP, US Pharmaceutical Regulations, US

Clinical Trial Process, Global Regulatory Strategy, IND, CTD and NDA

PhD, Biophysics Ohio State University Columbus, OH

BS, Biochemistry University of Delaware Newark, DE

PUBLICATIONS

1. Bai L, Yang H, Hu Y, Doran A, Goldberger N, NCI Sequencing Core, Lee M,

Keane T, Pandolfi PP, Hunter KW. An integrated genome-wide systems

genetics screen for breast cancer metastasis susceptibility genes.

Submitted to Nature.

2. Faraji F, Hu Y, Wu G, Goldberger NE, Walker RC, Zhang J, Hunter KW. An

integrated systems genetics screen reveals the transcriptional structure

of inherited predisposition to metastatic disease. Genomic Research

2014; 24:227-40.

3. Hu Y, Bai L, Geiger T, Goldberger N, Walker RC, Green JE, Wakefield LM,

and Hunter KW. Genetic background may contribute to PAM50 gene

expression breast cancer subtype assignments. PLoS One 2013; 8:e72287.

4. Goldberger N, Walker RC, Kim CH, Winter S, and Hunter KW. Inherited

variation in miR-290 expression suppresses breast cancer progression by

targeting the metastasis susceptibility gene Arid4b. Cancer Research

2013; 73:2671-81.

5. Goldberger N, Hunter KW. A systems biology approach to defining

metastatic biomarkers and signaling pathways. Wiley Interdisciplinary

Reviews: Systems Biology and Medicine 2009; 1:89-96.

6. Bisson WH, Cheltsov AV, Bruey-Sedano N, Lin B, Chen J, Goldberger N, May

LT, Christopoulos A, Dalton JT, Sexton PM, Zhang XK, and Abagyan R.

Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed

drugs. PNAS 2007; 104:11927-32.

7. Mousses S, Bubendorf L, Wagner U, Hostetter G, Kononen J, Cornelison R,

Goldberger N, Elkahloun AG, Willi N, Koivisto P, Ferhle W, Raffeld M,

Sauter G, and Kallioniemi O-P. Clinical validation of candidate genes

associated with prostate cancer progression in the CWR22 model system

using tissue microarrays. Cancer Research 2002; 62:1256-60.

8. Rozenblum E, Vahteristo P, Sandberg T, Bergthorsson JT, Syrjakoski K,

Weaver D, Haraldsson K, Johannsdottir HK, Vehmanen P, Nigam S, Goldberger

N, Robbins C, Pak E, Dutra A, Gillander E, Stephan DA, Bailey-Wison J,

Hank Juo S-H, Kainu T, Arason A, Barkardottir RB, Nevanlinna H, Borg A,

and Kallioiemi O-P. A genomic map of a 6-Mb region at 13q21-q22

implicated in cancer development: identification and characterization of

candidate genes. Human Genetics 2002; 110:111-21.

9. Allander SV, Nupponen N, Ringner M, Hostetter G, Maher GW, Goldberger N,

Chen Y, Carpten J, Elkahloun AG, and Meltzer PS. Gastrointestinal

stromal tumors with KIT mutations exhibit a remarkably homogeneous gene

expression profile. Cancer Research 2001; 61:8624-8.[pic]

Contact this candidate